Evidence map›Paper›PMID 37936577›Full record

ArticleFrontiers in physiology2023

Characterization of the far-red fluorescent probe MitoView 633 for dynamic mitochondrial membrane potential measurement.

Patrick Ernst, Seulhee Kim, Zengqiao Yang, Xiaoguang Margaret Liu, Lufang Zhou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patrick ErnstDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Seulhee KimDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, United States.
Zengqiao YangDepartment of Surgery, The Ohio State University, Columbus, OH, United States.
Xiaoguang Margaret LiuDepartment of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH, United States.
Lufang ZhouDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
The Ohio State University · USUniversity of Alabama at Birmingham · US

Funding

Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancerR01CA262028 · NCI · OHIO STATE UNIVERSITY · PI Xiaoguang Margaret Liu, Eddy Shih Hsin Yang · 2022 to 2026
$2.8M
Synergistically Target Mitochondria for Heart Failure TreatmentR01HL160690 · NHLBI · OHIO STATE UNIVERSITY · PI Lufang Zhou · 2023 to 2026
$2.4M
Delineate the Pathophysiological Effect of Cardiomyocyte-specific Mitochondrial StressR01HL156581 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHOU, LUFANG · 2021 to 2025
$2.2M
NCI NIH HHS R01 CA262028NHLBI NIH HHS R01 HL156581NHLBI NIH HHS R01 HL160690
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

confocalenergeticslive cell imagingmitochondriamolecular probe

Identifiers

PMID37936577
PMCPMC10627182
OpenAlexW4387868992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.